AU Patent

AU695170B2 — Transdermal delivery system with adhesive overlay and peel seal disc

Assigned to Actavis Laboratories UT Inc · Expires 1998-08-06 · 28y expired

What this patent protects

Patent listed against donepezil-hydrochloride.

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: AU695170B2
Jurisdiction: AU
Classification: —
Expires: 1998-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Actavis Laboratories UT Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.